Back
Fortress Biotech, Inc. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
39
FBIO
Fortress Biotech, Inc.
Last Price:
$2.76
Seasonality Move:
14.98%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiFortress Biotech, Inc. Stock Forecast
-
Is Fortress Biotech, Inc. Stock Undervalued?The current Fortress Biotech, Inc. [FBIO] share price is $2.75. The Score for FBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
FBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Fortress Biotech, Inc. Stock Go Up Next Year?
Data Unavailable
Fortress Biotech, Inc. Stock Rating
Data Unavailable
Fortress Biotech, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
fortressbiotech.com
52-Week Data
52-Week High:
4.20
52-Week Low:
1.33
Prediction Charts
Market Cap:
85.4M
Price in USD:
2.75
Volume:
589.4K
Beta:
1.81
Technical Analysis
SMA50:
2.75
SMA100:
2.65
SMA200:
2.19
52-Wk Change:
26.15%
Stock Predictions
-
Is Fortress Biotech, Inc. stock public?Yes, Fortress Biotech, Inc. is a publicly traded company.
-
What is the Fortress Biotech, Inc. stock quote today?The Fortress Biotech, Inc. stock price is 2.75 USD today.
-
How to buy Fortress Biotech, Inc. stock online?You can buy Fortress Biotech, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 2.47 | 2.62 | 2.64 | 2.45 |
| Nov-17 | 2.65 | 2.61 | 2.73 | 2.53 |
| Nov-18 | 2.56 | 2.67 | 2.76 | 2.56 |
| Nov-19 | 2.70 | 2.60 | 2.70 | 2.55 |
| Nov-20 | 2.62 | 2.53 | 2.67 | 2.52 |
| Nov-21 | 2.51 | 2.59 | 2.61 | 2.50 |
| Nov-24 | 2.59 | 2.55 | 2.64 | 2.50 |
| Nov-25 | 2.54 | 2.69 | 2.70 | 2.54 |
| Nov-26 | 2.69 | 2.76 | 2.78 | 2.60 |
| Nov-28 | 2.76 | 2.82 | 2.86 | 2.76 |
| Dec-1 | 2.82 | 2.72 | 2.85 | 2.71 |
| Dec-2 | 2.72 | 2.57 | 2.72 | 2.56 |
| Dec-3 | 2.55 | 2.69 | 2.76 | 2.49 |
| Dec-4 | 2.66 | 2.75 | 2.85 | 2.63 |
Fortress Biotech, Inc. Earnings
Data Unavailable
Fortress Biotech, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.89 per share, and a decrease next year of $0.01 per share.
* Fortress Biotech, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.